While 33.3% of the patients with pancreatic cancer were found in the high HGF group, 46.2% of the patients with ampullary cancer were found in the high HGF group, and 72.7% of the patients with biliary tract cancer were in the high HGF group (P = .022). Here, HGF is linked to pancreatic neoplasm.